Evidence of large systematic differences between countries in assigning ischaemic heart disease deaths to myocardial infarction: the contrasting examples of Russia and Norway.
Myocardial infarction
Norway
Russia
autopsies
ischaemic heart disease
place of death
validity of causes of death
Journal
International journal of epidemiology
ISSN: 1464-3685
Titre abrégé: Int J Epidemiol
Pays: England
ID NLM: 7802871
Informations de publication
Date de publication:
06 01 2022
06 01 2022
Historique:
received:
02
12
2020
accepted:
17
08
2021
entrez:
9
1
2022
pubmed:
10
1
2022
medline:
22
3
2022
Statut:
ppublish
Résumé
There is considerable variation in mortality rates from myocardial infarction (MI) across high-income countries, some of which may be artefactual. Time trends in mortality rates from ischaemic heart disease (IHD) and MI were analysed for a set of high-income countries from the end of the 1970s. Using individual-level mortality data from Russia (2005-2017) and Norway (2005-2016), we investigated factors associated with the proportion of total IHD deaths certified as due to MI. In most countries, MI mortality rates have dramatically declined from the 1970s. However, the share of MI in total IHD deaths varies substantially across countries. In Russia, only 12% of IHD deaths had MI assigned as the underlying cause vs 63% in Norway. IHD deaths occurring outside of hospital without autopsy were far less likely to be assigned as MI in Russia (2%) than in Norway (59%). Although established international criteria for MI require specific clinical or post-mortem evidence, it appears that certifying specialists in different countries may interpret these criteria differently. At one extreme, Russian doctors may only assign MI as a cause of death when there is specific pathophysiological evidence. At the other extreme, their counterparts in Norway may be willing to specify MI as the cause even when this evidence is not available. Internationally established criteria for MI diagnosis are challenging to apply for out-of-hospital deaths. Differences between countries in how certifiers interpret these criteria may account for at least some of the international variation in MI mortality rates.
Sections du résumé
BACKGROUND
There is considerable variation in mortality rates from myocardial infarction (MI) across high-income countries, some of which may be artefactual.
METHODS
Time trends in mortality rates from ischaemic heart disease (IHD) and MI were analysed for a set of high-income countries from the end of the 1970s. Using individual-level mortality data from Russia (2005-2017) and Norway (2005-2016), we investigated factors associated with the proportion of total IHD deaths certified as due to MI.
RESULTS
In most countries, MI mortality rates have dramatically declined from the 1970s. However, the share of MI in total IHD deaths varies substantially across countries. In Russia, only 12% of IHD deaths had MI assigned as the underlying cause vs 63% in Norway. IHD deaths occurring outside of hospital without autopsy were far less likely to be assigned as MI in Russia (2%) than in Norway (59%).
CONCLUSIONS
Although established international criteria for MI require specific clinical or post-mortem evidence, it appears that certifying specialists in different countries may interpret these criteria differently. At one extreme, Russian doctors may only assign MI as a cause of death when there is specific pathophysiological evidence. At the other extreme, their counterparts in Norway may be willing to specify MI as the cause even when this evidence is not available. Internationally established criteria for MI diagnosis are challenging to apply for out-of-hospital deaths. Differences between countries in how certifiers interpret these criteria may account for at least some of the international variation in MI mortality rates.
Identifiants
pubmed: 34999891
pii: 6499416
doi: 10.1093/ije/dyab188
pmc: PMC8743129
doi:
pii:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2082-2090Subventions
Organisme : Wellcome Trust
ID : 100217/Z/12
Pays : United Kingdom
Organisme : Norwegian Ministry of Health, Norwegian Institute of Public Health, UiT The Arctic University of Norway
Organisme : HSE University Basic Research Program
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the International Epidemiological Association.
Références
Heart. 2002 Oct;88(4):343-7
pubmed: 12231588
Circulation. 2007 Nov 27;116(22):2634-53
pubmed: 17951284
Circulation. 1994 Jul;90(1):583-612
pubmed: 8026046
Forensic Sci Int. 2001 Jan 1;115(1-2):15-32
pubmed: 11056267
Lancet Public Health. 2017 Apr;2(4):e191-e201
pubmed: 29253451
Int J Epidemiol. 2011 Feb;40(1):139-46
pubmed: 20926369
Aust N Z J Public Health. 2011 Oct;35(5):466-76
pubmed: 21973254
Cancer Causes Control. 1992 Nov;3(6):541-6
pubmed: 1420857
Vestn Ross Akad Med Nauk. 2007;(7):17-27
pubmed: 17718076
Int J Epidemiol. 2010 Oct;39(5):1279-90
pubmed: 20591986
Eur J Epidemiol. 2003;18(9):871-8
pubmed: 14561046
Int J Epidemiol. 2009 Feb;38(1):143-53
pubmed: 18775875
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264
pubmed: 30153967
Circulation. 2013 Feb 12;127(6):749-56
pubmed: 23401116
Ann Epidemiol. 2011 Nov;21(11):824-9
pubmed: 21982485
Circulation. 2006 May 2;113(17):2071-81
pubmed: 16636170
Ann Intern Med. 1998 Dec 15;129(12):1020-6
pubmed: 9867756
Bull World Health Organ. 2005 Mar;83(3):171-7
pubmed: 15798840
Eur Heart J. 2000 Sep;21(18):1502-13
pubmed: 10973764
Int J Cardiol. 2016 Nov 15;223:660-664
pubmed: 27567235
PLoS One. 2014 Mar 28;9(3):e92286
pubmed: 24682186
J Epidemiol Community Health. 2020 Sep;74(9):698-704
pubmed: 32414935
BMC Cardiovasc Disord. 2020 Mar 13;20(1):135
pubmed: 32169049